TEIJIN Ltd.
Japan Tissue Engineering Co., Ltd.
Mitsui Fudosan Co., Ltd.
National Cancer Center, National Cancer Center
(Headquarters: Kita-ku, Osaka; President: Tetsushige Uchikawa; hereinafter referred to as Teijin), Japan Tish Engineering Co., Ltd. (Headquarters: Gamagori City, Aichi Prefecture; President: Kenichiro Hata; hereinafter "J-TEC), Mitsui Fudosan Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President: Masanobu Komoda; hereinafter referred to as Mitsui Fudosan Co., Ltd.; Headquarters: Chuo-ku, Chiba Prefecture; President: Chuo-ku, Chiba Prefecture; President: Chuo-ku; President: Chuo-ku; President: Chuo-ku; President: Chuo-ku; President: Chuo-ku, Tokyo; President: Chuo-ku; President: Chuo-ku; hereinafter referred to as Mitsui Fudosan; hereinafter referred to as Mitsui Fudosan; President: Chuo-ku; President: Chuo-ku; President: Chuo-ku, Tokyo; President: In particular, we aim to accelerate the commercialization of regenerative medicine and other products related to cancer and contribute to society through the provision of innovative therapies originating in Japan.
Next is here.